Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study - Wikidata - awgldk - TriplyDB

Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study

Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study

http://www.wikidata.org/entity/Q41195176

about

Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overview Validation of functional imaging as a biomarker for radiation treatment response Imaging tumour hypoxia with positron emission tomography Imaging tumor hypoxia to advance radiation oncology The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities Positron emission tomography to assess hypoxia and perfusion in lung cancer Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer Introduction to the analysis of PET data in oncology.18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.Recent advances in radiotherapy.Molecular mechanisms of hypoxia in cancer.Clinical biomarkers for hypoxia targeting Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.Broadening the scope of image-guided radiotherapy (IGRT).18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma Functional and molecular image guidance in radiotherapy treatment planning optimization.The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy.F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy Multimodality functional imaging in radiation therapy planning: relationships between dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET.Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot s An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy.Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.PET/CT in Radiotherapy Planning for Head and Neck Cancer Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.One-stop-shop tumor imaging: buy hypoxia, get lactate free.Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.Clinical application of intensity-modulated radiotherapy for head and neck cancer.A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.Molecular imaging of cancer: evaluating characters of individual cancer by PET/SPECT imaging.Recent advances in image-guided radiotherapy for head and neck carcinoma.Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings

P2860

Q26767172-167D9074-F623-4CAE-8F55-EE8F3C40D8A0 Q26823165-620B3B1D-8A8B-4A8A-B32A-918A88584DDD Q26851422-AFC601BE-493C-4F2D-8292-51CBB9D73C03 Q27007862-3DB8075B-5E4B-4D76-A8DC-6F9E0BF44E2E Q27025579-2634A73F-0C13-493D-817E-2621EDA5424B Q27026940-3A0880DF-AC08-4BB6-AAD0-540A3D23CCFE Q28821970-2DFA9644-C06F-4590-AE84-7B278EE1818F Q30594766-89951BC2-3391-477C-877F-D477DA5E752B Q30660095-253017F9-0620-4F3A-8555-56CEEAFA5301 Q30884020-77B41974-9F4F-4BCE-A31C-5B102D0F8B41 Q31165401-1B0428F8-8AA0-46F9-A6C4-BB1D76CE337C Q33275483-BABF80E0-3F2E-4275-972F-43717BAD1CF9 Q33567305-F85787F0-05CB-4D86-907A-7ADD89225B2C Q33705108-3339B98A-4F09-4E7B-AF82-BF385B8CA9FD Q33714638-B3CC5837-D55E-43C5-8C4D-1C4B7C0B9D45 Q33723814-40E74A17-1355-4F48-814E-ED9AACB65A44 Q33818999-80378194-6D68-41D7-9B2B-0D23E7899529 Q33925417-4F2DD4BA-E2AA-41BB-8F13-255CD9ECFBA0 Q33943514-A61A0BF5-B16E-445E-B104-77DAC791561C Q33973367-F4904494-D162-40D8-9FF8-5E65D61895ED Q34029591-7476FFC1-7E80-45F5-B748-C070454CE682 Q34706820-9C9B6E81-BF68-40EB-B441-0842F087C411 Q35111985-ABA209B6-8E90-48B0-9CDF-F901085E8855 Q35116993-EEB1CF9D-91EF-4100-900C-ABD007655FF4 Q35151522-88768D20-CFAB-4C9D-B029-B603A399D1A9 Q36153707-FF764A07-2387-4179-A978-F00F9E6BF83F Q36173661-ED8B2CE1-B199-4859-9009-7E4934F5F986 Q36300626-678F23A3-9F60-4D54-860F-A21DC12A962B Q36343896-6DD2E589-F498-4465-BC82-808D170196D2 Q36455944-90BBD209-478F-4AFB-934B-E744963C3CCE Q36529838-0CE37D70-983D-4DAA-A211-06808C9FB73E Q36570510-F58790BA-015E-4E57-8813-0E25BCD33802 Q36770099-17A34C34-AB17-4B74-9F25-06DE16FD7AA0 Q37201935-C3E647C7-B89A-47D0-9C97-B676BDD6BC66 Q37217016-4C918199-31AF-493B-BB75-6650BDCBF4DD Q37297234-D5057499-0EAF-427C-8C8F-63B161BDC37A Q37333035-0191454D-B7DE-4917-A09F-001E48AADD75 Q37372774-B66D3A74-D817-4D28-AFC0-CAE8CC75EBDA Q37567466-53331CFA-B299-46A4-8173-F5A4F3E616B3 Q37604088-135D09B5-F7F2-41B9-BE44-85B17F469AEF

P2860

Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study

http://www.wikidata.org/entity/Q41195176

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Fluorine-18-labeled fluoromiso ...... ck cancer: a feasibility study

@en

type

label

Fluorine-18-labeled fluoromiso ...... ck cancer: a feasibility study

@en

prefLabel

Fluorine-18-labeled fluoromiso ...... ck cancer: a feasibility study

@en

P1433

Q41195176-1CF53AEB-911C-45BC-9699-07A69FAC8B85

P1476

Q41195176-699EF01F-9BBC-499B-9C11-8A512E99B93A

P2093

Q41195176-0021FA0F-E9F4-4DBA-B42B-8D8986BAA2BC

Q41195176-19120BA9-E0BE-4672-8735-504425472254

Q41195176-1C7E5F76-25CD-4B27-89A8-F381B9F0C3A9

Q41195176-20E960EC-9D74-4E3E-9FED-0E3A3B0F60D4

Q41195176-4C77F914-27BF-4514-AA90-70AECB7ED3E7

Q41195176-79DE9824-F8ED-4091-B65F-87424BFBE03D

Q41195176-9AE1BC59-E798-44AD-9856-C16B939FBB79

Q41195176-B46DF5A6-3F49-4D5F-9C6A-5E33469357A4

Q41195176-BCA535BF-F84A-474F-8358-BC9DA40E7A39

Q41195176-DE3BBD1F-7100-4349-9A74-FC96BAAF9A49

P2860

Q41195176-01BC2BFB-D255-427B-B8FF-7D07E328492E

Q41195176-03195B66-6AC7-487C-9C3B-26CA89EAD243

Q41195176-0560E2C7-B3FE-42E7-A690-25C8B3108CCF

Q41195176-0746F846-3487-4251-AB4C-A8D4427E5F87

Q41195176-0C223731-838F-48EC-97BC-370E7D4D2F2B

Q41195176-0DD08EA0-46E1-414D-B308-2255ECEFE2EB

Q41195176-0FB5A494-88E9-4FB6-9464-D52C8A6C06ED

Q41195176-12B2CE87-B374-4CAA-97CC-3EAEA812BAB2

Q41195176-13AD3770-65F8-454C-9C9F-1D9D403B4846

Q41195176-19DE071C-528D-47CB-B04A-E6D1FD1C19BB

P304

Q41195176-CDDEE375-772F-4283-A46D-6B570F746ECA

P31

Q41195176-70C45CFE-55BD-4930-87D7-A080852A8E66

P356

Q41195176-65DB6213-E6CA-4115-852D-3FA906755DC4

P407

Q41195176-4344E1D3-A0F0-47BB-94C9-8156989089DC

P433

Q41195176-B51166C2-85E2-433B-B59D-FA4D8049D4EE

P478

Q41195176-C6B4CEB6-F7B9-4270-84C3-A82650FE8EA0

P50

Q41195176-10645720-49D7-4A13-B517-EF7E5EB9D24C

P577

Q41195176-0AC9DBE8-16DD-4E88-A41F-A6CC2D4B7BFE

P5875

Q41195176-4F6B0608-A859-4586-BC36-3F6C40CA44EF

P698

Q41195176-F8333D1C-2816-43F6-8CB5-03B14A2F6903

P921

Q41195176-0BD9EE19-1488-43F9-AC50-5AC9549F170F

P932

Q41195176-6A567B36-DF8D-473B-91BF-91998911FA31

P356

J.IJROBP.2007.06.039

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Fluorine-18-labeled fluoromiso ...... ck cancer: a feasibility study

@en

P2093

Carlo Greco

http://www.w3.org/2001/XMLSchema#string

Clifton C Ling

http://www.w3.org/2001/XMLSchema#string

Heiko Schöder

http://www.w3.org/2001/XMLSchema#string

John L Humm

http://www.w3.org/2001/XMLSchema#string

Kelvin Chan

http://www.w3.org/2001/XMLSchema#string

Nancy Y Lee

http://www.w3.org/2001/XMLSchema#string

Olivia D Squire

http://www.w3.org/2001/XMLSchema#string

Pasquale B Zanzonico

http://www.w3.org/2001/XMLSchema#string

Sadek Nehmeh

http://www.w3.org/2001/XMLSchema#string

Shangde Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

Positron emission tomography for radiation treatment planning.

Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.

Hypoxia-Specific Cytotoxins in Cancer Therapy.

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

Intensity modulated radiation therapy: a clinical review.

Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

P304

2-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2007.06.039

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

James Mechalakos

P577

2007-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5971732

http://www.w3.org/2001/XMLSchema#string

P698

17869020

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2888477

http://www.w3.org/2001/XMLSchema#string